These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19235893)

  • 1. Protein product of CLN6 gene responsible for variant late-onset infantile neuronal ceroid lipofuscinosis interacts with CRMP-2.
    Benedict JW; Getty AL; Wishart TM; Gillingwater TH; Pearce DA
    J Neurosci Res; 2009 Jul; 87(9):2157-66. PubMed ID: 19235893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.
    Morgan JP; Magee H; Wong A; Nelson T; Koch B; Cooper JD; Weimer JM
    PLoS One; 2013; 8(11):e78694. PubMed ID: 24223841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the autophagy-lysosome pathway is involved in neuropathology of the nclf mouse model of neuronal ceroid lipofuscinosis.
    Thelen M; Damme M; Schweizer M; Hagel C; Wong AM; Cooper JD; Braulke T; Galliciotti G
    PLoS One; 2012; 7(4):e35493. PubMed ID: 22536393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells.
    Cao Y; Staropoli JF; Biswas S; Espinola JA; MacDonald ME; Lee JM; Cotman SL
    PLoS One; 2011 Feb; 6(2):e17118. PubMed ID: 21359198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis.
    Bartsch U; Galliciotti G; Jofre GF; Jankowiak W; Hagel C; Braulke T
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6952-9. PubMed ID: 24084090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein.
    Wheeler RB; Sharp JD; Schultz RA; Joslin JM; Williams RE; Mole SE
    Am J Hum Genet; 2002 Feb; 70(2):537-42. PubMed ID: 11727201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation.
    Mirza M; Volz C; Karlstetter M; Langiu M; Somogyi A; Ruonala MO; Tamm ER; Jägle H; Langmann T
    PLoS One; 2013; 8(10):e75963. PubMed ID: 24124525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLN6 deficiency causes selective changes in the lysosomal protein composition.
    Tuermer A; Mausbach S; Kaade E; Damme M; Sylvester M; Gieselmann V; Thelen M
    Proteomics; 2021 Oct; 21(19):e2100043. PubMed ID: 34432360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An altered secretome is an early marker of the pathogenesis of CLN6 Batten disease.
    Best HL; Clare AJ; McDonald KO; Wicky HE; Hughes SM
    J Neurochem; 2021 May; 157(3):764-780. PubMed ID: 33368303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9.
    Bronson RT; Donahue LR; Johnson KR; Tanner A; Lane PW; Faust JR
    Am J Med Genet; 1998 May; 77(4):289-97. PubMed ID: 9600738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.
    Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF
    Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Japanese variant of late infantile neuronal ceroid lipofuscinosis caused by novel CLN6 mutations.
    Sato R; Inui T; Endo W; Okubo Y; Takezawa Y; Anzai M; Morita H; Saitsu H; Matsumoto N; Haginoya K
    Brain Dev; 2016 Oct; 38(9):852-6. PubMed ID: 27165443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis.
    Kanninen KM; Grubman A; Meyerowitz J; Duncan C; Tan JL; Parker SJ; Crouch PJ; Paterson BM; Hickey JL; Donnelly PS; Volitakis I; Tammen I; Palmer DN; White AR
    PLoS One; 2013; 8(3):e58644. PubMed ID: 23516525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Photoreceptor Cell Loss in a Cln6
    Kleine Holthaus SM; Ribeiro J; Abelleira-Hervas L; Pearson RA; Duran Y; Georgiadis A; Sampson RD; Rizzi M; Hoke J; Maswood R; Azam S; Luhmann UFO; Smith AJ; Mole SE; Ali RR
    Mol Ther; 2018 May; 26(5):1343-1353. PubMed ID: 29606505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: a case report.
    Sun G; Yao F; Tian Z; Ma T; Yang Z
    BMC Med Genet; 2018 Oct; 19(1):177. PubMed ID: 30285654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis.
    Teixeira CA; Espinola J; Huo L; Kohlschütter J; Persaud Sawin DA; Minassian B; Bessa CJ; Guimarães A; Stephan DA; Sá Miranda MC; MacDonald ME; Ribeiro MG; Boustany RM
    Hum Mutat; 2003 May; 21(5):502-8. PubMed ID: 12673792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse.
    Gao H; Boustany RM; Espinola JA; Cotman SL; Srinidhi L; Antonellis KA; Gillis T; Qin X; Liu S; Donahue LR; Bronson RT; Faust JR; Stout D; Haines JL; Lerner TJ; MacDonald ME
    Am J Hum Genet; 2002 Feb; 70(2):324-35. PubMed ID: 11791207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of disease-related Cln6 in the cerebral cortex, purkinje cells, dentate gyrus, and hippocampal ca1 neurons.
    Thelen M; Fehr S; Schweizer M; Braulke T; Galliciotti G
    J Neurosci Res; 2012 Mar; 90(3):568-74. PubMed ID: 22012656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.
    Kielar C; Wishart TM; Palmer A; Dihanich S; Wong AM; Macauley SL; Chan CH; Sands MS; Pearce DA; Cooper JD; Gillingwater TH
    Hum Mol Genet; 2009 Nov; 18(21):4066-80. PubMed ID: 19640925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure susceptibility, phenotype, and resultant growth delay in the nclf and mnd mouse models of neuronal ceroid lipofuscinoses.
    Kriscenski-Perry E; Kovács AD; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1137-41. PubMed ID: 23838029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.